LA ROCHE POSAY

UPC: 883140500162

805687
Authorized Retailer
All Products are Guaranteed Authentic and Fresh

Free Full Size (4oz) Ageless Derma Anti-Aging Cleanser with purchase of $65
La Roche Posay Anthelios Broad Spectrum UVA/UVB Protection 40 1.7oz

La Roche Posay Anthelios Broad Spectrum UVA/UVB Protection 40 1.7oz

LRP_ANT40
Mexoryl 153; SX is the new sun filter in the only sunscreen formulas that have been specifically approved by the FDA for protection against short UVA rays.
$35.98

Detailed Description

La Roche Posay Anthelios Broad Spectrum UVA/UVB Protection 40 1.7oz

Recommended For
All adults and children (6 months and older) concerned with the prevention of skin cancer, skin aging, and hyperpigmentation.
Specifically tested on photosensitive skin.
Product Information
New FDA approval! ANTHELIOS 40 sunscreen cream with SPF 40, the highest UVA & UVB protection in a sunscreen with Mexoryl™ SX, specifically tested on photosensitive skin. Recommended for outdoor use.
Benefits
High UVA protection with 3% Mexoryl™ SX (highest concentration)
SPF 40
High photostability (resists losing efficacy in the sun)
Broad-spectrum UVA/UVB protection
Tested safe on photosensitive skin
Tested safe for children
Non-comedogenic
Dry finish texture (non-greasy)
Suitable for sensitive skin
Fragrance-free, PABA-free
Dermatologist and allergy-tested
Clinical studies
1 year safety study on patients with PMLEÃù
Clinical pediatric safety studyÃò
Key Ingredients
Mexoryl™ SX 3% protects against short UVA rays and is photostable on its own
Octocrylene 10% protects against UVB rays
Avobenzone 2% protects against long UVA rays and is stabilized by Octocrylene
Titanium Dioxide 5% provides enhanced overall UVA and UVB protection
Directions
Apply evenly 15 minutes before sun exposure
Reapply as needed or after towel drying, swimming or perspiring
Children under 6 months of age: ask a doctor
Disclaimer
ÃùData on file: 1 year safety study conducted on 475 patients with photosensitive skin including those with PMLE
ÃòData on file: Clinical 6-month pediatric safety study conducted on 135 children aged 6 months to 12 years

Product Reviews

Rate This Product:
or Create a Review
(0 Ratings, 0 Reviews)